ActLight: Ultra Small, Very Low Power Consumption Heart Rate Monitoring Sensor for Hearables? You Need the ActLight Dynamic Photodiode

LAUSANNE, Switzerland, Nov. 25, 2019 /PRNewswire/ — Long battery life, precision of measurements and very small size are the key requirements for vital signs monitoring sensors in hearable devices.

Despite ultra small detector area (70dB SNR. In addition, the ActLight solution provides a very strong output signal without AFE, further reducing the power consumption of the overall system.

The Dynamic PhotoDiode is the vital signs monitoring sensor of choice to meet the very demanding technical requirements of the hearable devices market.

For more information, contact us at info@act-light.com

About ActLight: ActLight SA, the company founded in 2011 and based in Switzerland, focuses on CMOS photonics and licenses its IP to customers in this field.

The patented CMOS-based photonics technology allows the substantial improvement of the efficiency and accuracy of various light sensing applications, such as Time-Of-Flight (TOF) based range meters, vital signs monitoring, 3D/2D cameras and much more. ActLight operates in the Internet of Things (IoT) market, with a focus on mobile and wearable devices, healthcare/medtech, autonomous driving, drones and robotics.

Photo – https://healthtechnologynet.com/wp-content/uploads/2019/11/ActLight_Dynamic_PhotoDiode.jpg  
Logo – https://healthtechnologynet.com/wp-content/uploads/2019/11/ActLight_Logo.jpg

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/actlight-ultra-small-very-low-power-consumption-heart-rate-monitoring-sensor-for-hearables-you-need-the-actlight-dynamic-photodiode-300964257.html

SOURCE ActLight

Staff

Recent Posts

Massimo Group Signs Letter of Intent to Acquire 100% of AI technology company FST in Drive to Accelerate Its AI-Powered Mobility and Health Technology Strategy

GARLAND, Texas, Feb. 3, 2026 /PRNewswire/ -- Massimo Group (NASDAQ: MAMO) ("Massimo" or the "Company"),…

48 minutes ago

Baysient Launches iDose® GEN7.0, Expanding Precision Dosing Platform to 16 Inflammatory Disease Indications

Next-Generation Decision Support Software Introduces Predictive Clinical Tools for Gastroenterology, Rheumatology, Dermatology, and PulmonologyFORT MYERS,…

49 minutes ago

From the Founders of Fitbit: Introducing Luffu, Your Guardian for Family Health & Safety

After making personal health accessible to millions with Fitbit, James Park and Eric Friedman announce…

49 minutes ago

Embla Medical hf: Interim Report Q4 and Full Year 2025

COPENHAGEN, Denmark, Feb. 3, 2026 /PRNewswire/ -- Announcement no. 5/2026 Interim Report Q4 and Full…

49 minutes ago

UAE Partners with Colossal Biosciences to Protect Biodiversity and Champion the Future of Life on Earth

The collaboration positions the UAE as a global leader in conservation, driving pioneering initiatives in…

49 minutes ago

Case Reports in Regrowth Announces Publication of Muhammad Qasim Observational Case Report and Invites Medical Review

New York, New York--(Newsfile Corp. - February 3, 2026) - Case Reports in Regrowth today…

1 hour ago